Jorge Celis Mejia (@jorgecelism) 's Twitter Profile
Jorge Celis Mejia

@jorgecelism

Trabajo contra el Ataque cerebrovascular (Infarto o derrame cerebral)

ID: 1523424604148150273

calendar_today08-05-2022 22:08:55

632 Tweet

234 Takipçi

61 Takip Edilen

World Stroke Academy (@worldstrokeed) 's Twitter Profile Photo

🎓New #IschemicStroke e-Learning module available! world-stroke-academy.org/courses/wso-ws… 👉Stroke care: from pre-hospital management to advanced treatment strategies Duration: 5 hours ✍ Complete the quiz and get your certificate of completion! #StrokeEducation #MedicalLearning

🎓New #IschemicStroke e-Learning module available!

world-stroke-academy.org/courses/wso-ws…

👉Stroke care: from pre-hospital management to advanced treatment strategies

Duration: 5 hours
 
✍ Complete the quiz and get your certificate of completion!

#StrokeEducation #MedicalLearning
AshuJadhav (@ashupjadhav) 's Twitter Profile Photo

Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours | New England Journal of Medicine nejm.org/doi/full/10.10…

Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours | New England Journal of Medicine nejm.org/doi/full/10.10…
World Stroke Academy (@worldstrokeed) 's Twitter Profile Photo

#Mondaytip ☝️After #ICH, patients aren't only at risk of recurrence but also IS👉especially w/AF After COCROACH metaanalysis, PRESTIGE-AF is the 1st large RCT to provide new data ⚖️Stroke prevention and bleeding risk remains critical Awaiting results from at least 2+ ongoing RCTs

#Mondaytip
☝️After #ICH, patients aren't only at risk of recurrence but also IS👉especially w/AF
After COCROACH metaanalysis, PRESTIGE-AF is the 1st large RCT to provide new data
⚖️Stroke prevention and bleeding risk remains critical
Awaiting results from at least 2+ ongoing RCTs
Shadi Yaghi (@shadiyaghi2) 's Twitter Profile Photo

Also look for the “Salted Pretzel” sign. Multiple calcified emboli. Source is carotid artery, aortic arch, or heart valve. Less commonly AF.

Also look for the “Salted Pretzel” sign. 

Multiple calcified emboli.

Source is carotid artery, aortic arch, or heart valve. Less commonly AF.
Jeyaraj Pandian (@jeyaraj_pandian) 's Twitter Profile Photo

Honored to deliver the Prof. Jacob Chandy Oration at the Department of Neurological Sciences, Christian Medical College, Vellore—celebrating the legacy of the father of Neurological Sciences in India. Spoke on “From Policy to Practice: A Roadmap for Strengthening Stroke Care in

Honored to deliver the Prof. Jacob Chandy Oration at the Department of Neurological Sciences, Christian Medical College, Vellore—celebrating the legacy of the father of Neurological Sciences in India.
Spoke on “From Policy to Practice: A Roadmap for Strengthening Stroke Care in
Stroke AHA/ASA (@strokeaha_asa) 's Twitter Profile Photo

#STROKE: Characteristics and temporal dynamics of acute symptomatic seizures may be used to predict mortality and the development of poststroke epilepsy among patients with ischemic stroke who were free of seizures at baseline. Marian Galovic #AHAJournals ahajournals.org/doi/full/10.11…

#STROKE: Characteristics and temporal dynamics of acute symptomatic seizures may be used to predict mortality and the development of poststroke epilepsy among patients with ischemic stroke who were free of seizures at baseline. <a href="/GalovicMarian/">Marian Galovic</a> #AHAJournals ahajournals.org/doi/full/10.11…
World Stroke Academy (@worldstrokeed) 's Twitter Profile Photo

🗓Don’t miss 'The Future of Stroke Treatment: Insights from AI & Tech', May 12 🔹AI in neuroimaging 🔹The UMBRELLA Project 🔹Ambulance stroke systems 👩🏽‍💻 Chair: Gisele Sampaio 🎙Carlos Molina, #DavidHargroves, #OnaWu 👉 Register: us02web.zoom.us/webinar/regist… #StrokeEducation

🗓Don’t miss 'The Future of Stroke Treatment: Insights from AI &amp; Tech', May 12

🔹AI in neuroimaging
🔹The UMBRELLA Project
🔹Ambulance stroke systems

👩🏽‍💻 Chair: <a href="/GiseleSampaioS/">Gisele Sampaio</a> 
 🎙<a href="/carlosmictusvh/">Carlos Molina</a>, #DavidHargroves, #OnaWu
👉 Register: us02web.zoom.us/webinar/regist…

 #StrokeEducation
JNIS (@jnis_bmj) 's Twitter Profile Photo

🚨 Exciting new findings in stroke treatment! 🚨 A study from JNIS reveals that cangrelor shows comparable safety and efficacy to GPIIb/IIIa inhibitors in large vessel occlusion stroke. With favorable pharmacokinetics, this promising agent could revolutionize acute stroke

🚨 Exciting new findings in stroke treatment! 🚨

A study from <a href="/JNIS_BMJ/">JNIS</a> reveals that cangrelor shows comparable safety and efficacy to GPIIb/IIIa inhibitors in large vessel occlusion stroke. With favorable pharmacokinetics, this promising agent could revolutionize acute stroke
World Stroke Org (@worldstrokeorg) 's Twitter Profile Photo

𝗝𝗼𝗶𝗻 𝘂𝘀 𝗮𝘁 #𝗪𝗛𝗔𝟳𝟴 𝗳𝗼𝗿 '𝗢𝘃𝗲𝗿𝗹𝗼𝗼𝗸𝗲𝗱 𝗮𝗻𝗱 𝗨𝗻𝗱𝗲𝗿𝗳𝘂𝗻𝗱𝗲𝗱' 𝗮 𝗽𝗶𝘃𝗼𝘁𝗮𝗹 𝗴𝗹𝗼𝗯𝗮𝗹 𝘀𝘁𝗿𝗼𝗸𝗲 𝗮𝗱𝘃𝗼𝗰𝗮𝗰𝘆 𝗲𝘃𝗲𝗻𝘁 𝗮𝗵𝗲𝗮𝗱 𝗼𝗳 𝘁𝗵𝗲 #𝗨𝗡𝗛𝗟𝗠 𝗼𝗻 #𝗡𝗖𝗗𝘀 𝗣𝗿𝗼𝗴𝗿𝗮𝗺 𝗼𝘃𝗲𝗿𝘃𝗶𝗲𝘄 𝗪𝗵𝘆 𝗦𝘁𝗿𝗼𝗸𝗲? 𝗪𝗵𝘆

Stroke AHA/ASA (@strokeaha_asa) 's Twitter Profile Photo

The No-Reflow Paradox: Unblocking the Vessel, Not the Damage? In this #BloggingStroke post, Shravan Sivakumar discusses #Stroke article by Rivet et al. #AHAJournals Professor Stephen Davis @teddyyhwu Professor Geoffrey Donnan AO ahajrnls.org/43iyPpP

The No-Reflow Paradox: Unblocking the Vessel, Not the Damage?

In this #BloggingStroke post, <a href="/sshravanMD/">Shravan Sivakumar</a> discusses #Stroke article by Rivet et al. #AHAJournals <a href="/ProfSteveDavis/">Professor Stephen Davis</a> @teddyyhwu <a href="/GeoffreyDonnan/">Professor Geoffrey Donnan AO</a>

ahajrnls.org/43iyPpP
World Stroke Academy (@worldstrokeed) 's Twitter Profile Photo

#ESOC2025 ✅ASSET-IT: early tirofiban after IVT 👉🏻>mRS 0-1 and 0-2 at 90 day in Tirofiban arm 👉🏻 = sICH and mortality al 90 days

#ESOC2025
✅ASSET-IT: early tirofiban after IVT

👉🏻&gt;mRS 0-1 and 0-2 at 90 day in Tirofiban arm

👉🏻 = sICH and mortality al 90 days
World Stroke Academy (@worldstrokeed) 's Twitter Profile Photo

#ESOC2025 🏃🏻‍♀️ESCAPE MEVO sub analysis 👉🏻 prognosis by image 🧠 👉🏻EVT <12 hs not > good functional outcome 👉🏻 Good collateral status > benefit 👉🏻 ⏱️<180 min > benefit

#ESOC2025
🏃🏻‍♀️ESCAPE MEVO sub analysis 

👉🏻 prognosis by image 🧠
👉🏻EVT &lt;12 hs not &gt; good functional outcome 
👉🏻 Good collateral  status &gt; benefit
👉🏻 ⏱️&lt;180 min &gt; benefit
World Stroke Academy (@worldstrokeed) 's Twitter Profile Photo

#ESOC2025 🦵🏽EECP for improve cerebral vasodilatory reserve (on SPECT) in ICAD patient 1hr/d, 5 times/week 122 randomized patients, 58y, 61%males ✅EECP was associated with significant improvement in hemodynamic parameters

#ESOC2025

🦵🏽EECP for improve cerebral vasodilatory reserve (on SPECT) in ICAD patient
1hr/d, 5 times/week
122 randomized patients, 58y, 61%males

✅EECP was associated with significant improvement in hemodynamic parameters
Andreas Charidimou MD, PhD (@a_charidimou) 's Twitter Profile Photo

📚🧠5 Essential Neurology Books (Residency basics) 1. Clinical Neurology & Neuroanatomy Aaron Berkowitz 2. How to think like a neurologist Ethan Meltzer, MD 3. The Acute Neurology Survival Guide Casey Albin, MD 4. The Code Stroke Handbook Andrew Micieli 5. Brainspotting Andrew Lees

📚🧠5 Essential Neurology Books (Residency basics)

1. Clinical Neurology &amp; Neuroanatomy <a href="/AaronLBerkowitz/">Aaron Berkowitz</a>
2. How to think like a neurologist <a href="/emeltzermd/">Ethan Meltzer, MD</a>
3. The Acute Neurology Survival Guide <a href="/caseyalbin/">Casey Albin, MD</a>
4. The Code Stroke Handbook <a href="/MicieliA_MD/">Andrew Micieli</a>
5. Brainspotting <a href="/ajlees/">Andrew Lees</a>
UCLA Neurology (@uclaneurology) 's Twitter Profile Photo

There have been recent trials that indicate how endovascular treatment (EVT) surprisingly offers significant benefit to patients with large-core #stroke. Dr. Jeffrey Saver offers further explanation and insight into these findings. pubmed.ncbi.nlm.nih.gov/40567239/

There have been recent trials that indicate how endovascular treatment (EVT) surprisingly offers significant benefit to patients with large-core #stroke. 

Dr. Jeffrey Saver offers further explanation and insight into these findings.

pubmed.ncbi.nlm.nih.gov/40567239/